Evidence of cardiomyocyte necrosis in glycogen storage disease type II

Annals of Clinical Biochemistry

Volumn 44, Issue 1, 2007, Pages 86-88

  Gaze, David C ^a   Lawson, Graham J ^b   Harris, Adam ^b   Collinson, Paul O ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b KENT AND SUSSEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CARDIAC TROPONIN T; CREATINE KINASE; TROPONIN T; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CASE REPORT; CELL DEATH; CLINICAL EXAMINATION; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; GENE MUTATION; GLYCOGEN STORAGE DISEASE TYPE 2; HEART MUSCLE CELL; HEART MUSCLE NECROSIS; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINUS BRADYCARDIA;

ADULT; BIOLOGICAL MARKERS; CHEST PAIN; ELECTROCARDIOGRAPHY; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; MALE; MYOCYTES, CARDIAC; NECROSIS; TROPONIN T;

EID: 33846467577     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456307779596048     Document Type: Article

References (14)

1. Pompe JC. Over idiopathische hypertriphie van he hart. Ned Tijdschr Genseesk 1932; 76: 304-11
2. Hers HG. Alpha-glucosidase deficiency in generalized glycogen storage disease (Pompe's disease). Biochem J 1963; 86: 11-6
3. Raben N, Plotz P, Byrne BJ. Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). Curr Mol Med 2002; 2: 145-66
4. Gillette PC, Nihill MR, Singer DB. Electrophysiological mechanism of the short PR interval in Pompe disease. Am J Dis Child 1974; 128: 622-6
5. Metzl JD, Elias ER, Berul CI. An interesting case of infant sudden death: severe hypertrophic cardiomyopathy in Pompe's disease. Pacing Clin Electrophysiol 1999; 22: 821-2
6. Ausems MG, Lochman P, van Diggelen OP, Ploos van Amstel HK, Reuser Aj, Wokke JH. A diagnostic protocol for adult-onset glycogen storage disease type II. Neurobiology 1999; 52: 851-3
7. Collinson PO, Boa FG, Gaze DC. Measurement of cardiac troponins. Ann Clin Biochem 2001; 38: 423-49
8. Anon. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21: 1502-13
9. Muller-Bardorff M, Hallermayer K, Schroder A, et al. Improved troponin T ELISA for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem 1997; 43: 458-66
10. Ricchuiti V, Voss EM, New A, Oderland M, Anderson PAW, Apple FS. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem 1998; 44: 1919-24
11. Baum H, Braun S, Gerhardt W, et al. Multicentre evaluation of a second generation assay for cardiac troponin T. Clin Chem 1994; 43: 1877-84
12. Gussenhoven WJ, Busch HF, Kleijer WJ, de Villeneuve VH. Echocardiographic features in the cardiac type of glycogen storage disease II. Eur Heart J 1983; 4: 41-3
13. Senocak F, Sarclar M, Ozkutlu S. Echocardiographic findings in some metabolic storage diseases. Jpn Heart J 1994; 35: 635-43
14. Gilbet-Barness E. Review: metabolic cardiomyopahty and conduction system defects in children. Ann Clin Lab Sci 2004; 34: 15-34